Discovery & Development

When looking to do good, many companies choose to focus on children’s health, particularly in developing countries.

The potential of inhaled drug delivery goes beyond traditional respiratory medicine.

If pharma wants to adopt continuous manufacturing, it must employ control procedures to ensure quality.

With approximately 80 percent of new drugs suffering from poor solubility and bioavailability, understanding solid form is more important than ever.

High-throughput excipient discovery looks set to boost oral bioavailability.

Nasal-bound nanoparticles could offer a novel way to bypass the blood-brain barrier

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

What are biosynthetic cannabinoids? And what do they mean for pharma?

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

How easy will it be to bring a new solid oral dosage form to market?